The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 28th 2024
Using multiple physicians or pharmacists can result in a lack of coordinated care, missed medication interactions, and overlooked contraindications.
FDA Approves Brolucizumab for Wet Age-Related Macular Degeneration
October 8th 2019Brolucizumab is the most clinically advanced humanized single-chain antibody fragment. This type of antibody is highly sought after due to their small size, enhanced tissue penetration, rapid clearance from systemic circulation, and drug delivery characteristics.
Read More
FDA Approves Trifarotene Cream for Acne Treatment
October 8th 2019Trifarotene is the only topical retinoid that selectively targets retinoic acid receptor (RAR) gamma, the most common RAR found in the skin. The cream is also the first topical treatment specifically studied and proven to treat both facial (forehead, cheeks, nose, and chin) and truncal (chest, shoulders, and back).
Read More
Treatment for C difficile Shows Promising Potential in First-in-Human Phase 1 Trial
October 6th 2019A first-in-human trial evaluating the safety, pharmacokinetics, and fecal microbiome effects of a novel DNA polIIIC inhibitor demonstrated the antibacterial’s promise as a potential treatment alternative to vancomycin for the treatment of Clostridioides difficile.
Read More
FDA Aims to Improve Oversight of Compounding Pharmacies with Data-Sharing System
October 4th 2019The FDA has awarded a cooperative agreement grant to the National Association of Boards of Pharmacy to develop a 3-year pilot project for a data-sharing system to improve oversight of compounding pharmacies.
Read More
Network of Research Centers Created for Development of Longer-Lasting Influenza Vaccines
October 1st 2019The National Institute of Allergy and Infectious Diseases (NIAID), which is a part of the National Institute of Health, has developed the Collaborative Influenza Vaccine Innovation Centers (CIVICs) program.
Read More
Canagliflozin Approved by FDA for Diabetes-Related Kidney Disease
September 30th 2019Officials from the FDA have approved the Janssen Pharmaceutical Companies of Johnson & Johnson’s canagliflozin (Invokana) to reduce the risk of end-stage kidney disease (ESKD) and cardiovascular events in patients with Type 2 Diabetes and chronic kidney disease (CKD).
Read More
Results from New Trial Show Vitamin D and Fish Oil Hopeful in Prevention of Cancer and CVD
September 25th 2019The vitamin D and omega-3 clinical trial (VITAL) is the largest, most recent study to test this subject matter, with nearly 26,000 United States men and women participating in the trial.
Read More
Company Halts Ranitidine Production Over NDMA Contamination Concerns
September 21st 2019After some lots of ranitidine were found to contain small amounts of N-nitrosodimethylamine (NDMA), Novartis's Sandoz unit has announced that they are halting distribution of ranitidine (Zantac) products until the contamination concerns are resolved.
Read More
London Mayor Calls for Broader Access to PrEP at Global HIV Conference
September 11th 2019London Mayor Sadiq Khan has called for broader availability of pre-exposure prophylaxis drugs in his welcoming speech at the Fast-Track Cities 2019 conference, where leaders from 300 cities around the world will discuss municipal responses to HIV, tuberculosis, and viral hepatitis.
Read More
Potential New ABSSSI Therapy Shows Positive Results in Study
September 10th 2019A recent phase 2 clinical trial found MicuRx Pharmaceuticals’ contezolid acefosamil (MRX-4) to be effective in treating acute bacterial skin and skin structure infections (ABSSSI) with dosing regimens that appeared to be safe and well-tolerated.
Read More
Rutgers University to Close All Student Pharmacies by Late Fall
September 9th 2019Hurtado Health Center, Busch-Livingston Health Center, and Cook Douglass Health Center will be closing after over a year of discussion, mainly due to budget constraints and a decline in use by the students in most recent years.
Read More